Schweitzer JS*, Song B*, Herrington TM*, Park T-Y*, Lee N*, Ko S, Jeon J, Cha Y, Kim K, Li Q, Henchcliffe C, Kaplitt M, Neff C, Rapalino O, Seo H, Lee I-H, Kim J, Kim T, Petsko GA, Ritz J, Cohen BM, Kong SW, Leblanc P, Carter BS, and Kim KS. Personalized iPSC-derived Dopamine Progenitor Cells for Parkinson’s Disease. N Eng J Med. 2020; 382:1926-1932 (* indicates co-first authors)
点击下载文件
Song B*, Cha Y*, Ko S*, Jeon J*, Lee N*, Seo H*, Park KJ, Lee IH, Lopes C, Feitosa M, Luna MJ, Jung JH, Kim J, Hwang D, Cohen BM, Teicher MH, Leblanc P, Carter BS, Kordower JH, Bolshakov VY, Kong SW, Schweitzer JS, Kim KS. Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson’s disease models. J. Clin. Invest. 2020;130:904-920. (featured in Commentary, Takahashi, J. J. Clin. Invest. 2020;130:601-603).
点击下载文件
Schweitzer JS*, Song B*, Leblanc PR, Feitosa M, Carter BS, Kim KS. Columnar Injection for intracerebral Cell therapy. Oper Neurosurg (Hagerstown). 2020;18:321-328. (* indicates co-firs authors)
点击下载文件
Rajan S, Jang Y, Kim CH, Kim W, Toh HT, Jeon J, Song B, Serra A, Lescar J, Yoo JY, Beldar S, Ye H, Kang C, Liu XW, Feitosa M, Kim Y, Hwang D, Goh G, Lim KL, Park HM, Lee CH, Oh SF, Petsko GA, Yoon HS, Kim KS. PGE1 and PGA1 bind to Nurr1 (NR4A2) and activate its transcriptional function. Nat. Chem. Biol., 2020;16:876-886.
点击下载文件
Sonntag KC, Song B, Lee N, Jung JH, Cha Y, Leblanc P, Neff C, Kong SW, Carter BS, Schweitzer J, Kim KS. Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects. Prog Neurobiol. 2018; 168:1-20.
点击下载文件
